Jordan vs Puerto Rico: Previously treated cases tested for RR-/MDR-TB
Jordan
100.0%
in 2024
Puerto Rico
100.0%
in 2023
Jordan rank
1st
Puerto Rico rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Jordan
- Puerto Rico
How they compare
Jordan currently reports 100.0% against 100.0% in Puerto Rico, a difference of 0.0%.
Across all 8 years both countries report, Puerto Rico has been ahead every year.
Jordan ranks 1st and Puerto Rico ranks 1st of 180 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jordan | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 41.7% | 87.5% | 45.8% | Puerto Rico |
| 2020s | 40.5% | 100.0% | 59.5% | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Jordan or Puerto Rico?
- Jordan, at 100.0% against 100.0% in Puerto Rico as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Jordan and Puerto Rico?
- 0.0%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Puerto Rico?
- 8 years are reported by both, from 2010 to 2023.
- How do Jordan and Puerto Rico rank globally for previously treated cases tested for rr-/mdr-tb?
- Jordan ranks 1st and Puerto Rico ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.